increased kidney tumor incidence_Tg(Pklr-HRAS*G12V)23Ak/0

http://metadb.riken.jp/0010294IC57BL6DBA2TgPklrHRASG12V23Ak0TgPklrHRASG12V23Ak

increased kidney tumor incidence_Tg(Pklr-HRAS*G12V)23Ak/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 23, Axel Kahn
  http://metadb.riken.jp/db/mgi_rdf/MGI:5428751

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Pklr-HRAS*G12V)23Ak/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Pklr-HRAS*G12V)23Ak

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6 * DBA/2

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased kidney tumor incidence
  http://purl.obolibrary.org/obo/MP_0010294

文献

http://purl.org/net/cito/citesAsAuthority

• E. Gilbert, et.al., In vivo effects of activated H-ras oncogene expressed in the liver and in urogenital tissues., International journal of cancer, 1997, 73
  http://rdf.ncbi.nlm.nih.gov/pubmed/9398057